A Digital Microfluidic Platform for the Microscale Production of Functional Immune Cell Therapies
Authors:
Preprint
Abstract
Genetically engineering human immune cells has been shown to be an effective approach for developing novel cellular therapies to treat a wide range of diseases. To expand the scope of these cellular therapies while solving persistent challenges, extensive research and development is still required. Electroporation has recently emerged as one of the most popular techniques for inserting biological payloads into human immune cells to perform genetic engineering. However, several recent studies have reported that electroporation can negatively impact cell functionality. Additionally, the requirement to use large amounts of cells and expensive payloads to achieve efficient delivery can drive up the costs of development efforts. Here we use a digital microfluidic enabled electroporation system (referred to as triDrop) and compare them against two state-of-the-art commercially available systems for the engineering of human T cells. We describe the ability to use triDrop for highly viable, highly efficient transfection while using substantially fewer cells and payload. Subsequently, we perform transcriptomic analysis on cells engineered with each of the three systems and show that electroporation with triDrop lead to less dysregulation of several functionally relevant pathways. Finally, in a direct comparison of immunotherapeutic functionality, we show that T cells engineered with triDrop have an improved ability to mount an immune response when presented with tumor cells. These results show that the triDrop platform is uniquely suited to produce functionally engineered immune cells while also reducing the costs of cell engineering compared to other commercially available systems.Keywords
All Related Versions
- Published version: Analytical Chemistry, 97 (21), 11026.
This publication has 72 references indexed in Scilit:
- Turnover of PPP1R15A mRNA encoding GADD34 controls responsiveness and adaptation to cellular stressCell Reports, 2024
- A Tri‐Droplet Liquid Structure for Highly Efficient Intracellular Delivery in Primary Mammalian Cells Using Digital MicrofluidicsAdvanced Materials Technologies, 2023
- CAR T cell therapy in solid tumors: A review of current clinical trialseJHaem, 2021
- Microfluidic and Nanofluidic Intracellular DeliveryAdvanced Science, 2021
- Cationic lipids for gene delivery: many players, one goalChemistry and Physics of Lipids, 2021
- Multi-phenotype CRISPR-Cas9 Screen Identifies p38 Kinase as a Target for Adoptive ImmunotherapiesCancer Cell, 2020
- Ribonucleoprotein Transfection for CRISPR/Cas9‐Mediated Gene Knockout in Primary T CellsCurrent Protocols in Immunology, 2018
- Mammalian cell transfection: the present and the futureAnalytical and Bioanalytical Chemistry, 2010
- A novel electroporation method using a capillary and wire-type electrodeBiosensors and Bioelectronics, 2008
- Changes of the solution pH due to exposure by high-voltage electric pulsesBioelectrochemistry, 2005